Selenium Status and Hemolysis in Sickle Cell Disease Patients

Area of Science:

• Biochemistry
• Hematology
• Nutritional Science

Background:

• Sickle cell disease (SCD) involves chronic hemolysis, exacerbated by oxidative stress.
• Antioxidant micronutrients like selenium may influence hemolysis severity in SCD.
• Understanding nutritional status is crucial for managing SCD complications.

Purpose of the Study:

• To assess the nutritional adequacy of antioxidant micronutrients (retinol, tocopherol, selenium, zinc) in SCD patients.
• To investigate the relationship between these antioxidants and the degree of hemolysis.
• To identify key nutritional determinants of hemolysis in sickle cell disease.

Main Methods:

• Serum levels of retinol, alpha-tocopherol, selenium, and zinc were measured in 51 adult SCD patients.
• Hematological parameters and inflammation markers were analyzed.
• Linear regression models were employed to determine associations between variables.

Main Results:

• A significant portion of SCD patients exhibited selenium deficiency and low dietary selenium intake.
• Selenium emerged as the primary determinant of hemolysis among the studied antioxidant nutrients.
• No significant associations were found between retinol, tocopherol, zinc, and hemolysis.

Conclusions:

• Selenium deficiency is a critical factor contributing to hemolysis in sickle cell disease.
• Current nutritional care protocols for SCD may need revision to include adequate selenium.
• Dietary interventions focusing on selenium could potentially reduce hemolysis risk in SCD patients.